Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    Management of type 2 diabetes mellitus: synopsis of the Department of Veterans Affairs and Department of Defense Clinical Practice Guideline

    Conlin, Paul R; Burke, Brian V; Hobbs, Curtis; Hurren, Kathryn M; Lang, Adam Edward; Morrison, John W; Spacek, Lance; Steil, Evan N; Watts, Sharon A; Weinreb, Jane E; Pogach, Leonard M.
    Mayo clin. proc; 24 (S0025-6196), 2024
    The US Department of Veterans Affairs (VA) and the US Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes. This was the product of a multidisciplinary guideline development committee composed of clinicians from both the VA and the DoD and was ove...
    Diabetes Mellitus Tipo 2/tratamiento farmacológico, Insulina, Control Glucémico, Calidad de Vida, Atención Dirigida al Paciente
    Texto completo

    Management of Dyslipidemia for cardiovascular disease risk Reduction: synopsis of the 2020 updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline

    O'Malley, Patrick G; Arnold, Michael J; Pharm, Cathy Kelley; Spacek, Lance; Buelt, Andrew; Natarajan, Sundar; Donahue, Mark P; Vagichev, Elena; Ballard-Hernandez, Jennifer; Logan, Amanda; Thomas, Lauren; Ritter, Joan; Neubauer, Brian E; Downs, John R.
    In June 2020, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) released a joint update of their clinical practice guideline for managing dyslipidemia to reduce cardiovascular disease risk in adults. This synopsis describes the major recommendations. The guideline panel de...
    Enfermedades Cardiovasculares/prevención & control, Enfermedades Cardiovasculares/diagnóstico, Dislipidemias/prevención & control, Dislipidemias/diagnóstico, Práctica Clínica Basada en la Evidencia, Rehabilitación Cardiaca, Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico
    Texto completo